Clinical Trials Directory

Trials / Completed

CompletedNCT00682162

Impact of Acupuncture on Vasomotor Rhinitis

Impact of Acupuncture on Vasomotor Rhinitis: a Randomised Placebo Controlled Pilot Study

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
24 (actual)
Sponsor
Ludwig-Maximilians - University of Munich · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

Chronic rhinitis without an allergic or infectious aetiology (vasomotor rhinitis) is a common disease for which there are only poor therapeutic treatment options. The current placebo controlled partially double blinded pilot study evaluated the effects of acupuncture on the symptoms of vasomotor rhinitis.

Conditions

Interventions

TypeNameDescription
DEVICEAcupunctureThe treatment consisted of 5 sessions, all patients completed a recovery time after treatment of 30 min duration. The sessions were administered over a period of 5 weeks (one session per week). The acupuncture treatment was semi-standardised. It consisted of a basic pool of 6 body acupuncture points. Five additional acupuncture body points together with auricular points formed an individual pool. After needle insertion, the needle was manipulated until the subject obtained the de-Qi response (a deep aching or full feeling at the needle, \[22\]). After obtaining the de-Qi response, there was no further manipulation of the needle. Each session lasted 20 minutes.
DEVICESham-laser acupunctureThe sham-laser acupuncture treatment consisted of 5 sessions, all patients completed a recovery time after treatment of 30 min duration. The sessions were administered over a period of 5 weeks (one session per week). Sham-laser acupuncture was applied at the same points as the acupuncture treatment. A deactivated laser pen (Seirin, 3B Scientific GmbH, Hamburg, Germany) that could only beam normal red light rather than laser was used. The total number of acupuncture points utilized was equal to the acupuncture group. Every point was treated for 30 sec with the total treatment time of 20 minutes.

Timeline

Start date
1998-01-01
Primary completion
1999-01-01
Completion
1999-06-01
First posted
2008-05-22
Last updated
2015-01-13

Locations

2 sites across 1 country: Germany

Source: ClinicalTrials.gov record NCT00682162. Inclusion in this directory is not an endorsement.